Stock Analysis on Net
Stock Analysis on Net

Gilead Sciences Inc. (NASDAQ:GILD)

$24.99

Balance Sheet: Liabilities and Stockholders’ Equity
Quarterly Data

The balance sheet provides creditors, investors, and analysts with information on company resources (assets) and its sources of capital (its equity and liabilities). It normally also provides information about the future earnings capacity of a company assets as well as an indication of cash flows that may come from receivables and inventories.

Liabilities represents obligations of a company arising from past events, the settlement of which is expected to result in an outflow of economic benefits from the entity.

Paying user area

Try for free

Gilead Sciences Inc. pages available for free this week:

The data is hidden behind: . Unhide it.

Get access

This is a one-time payment. There is no automatic renewal.

We accept:

Visa Mastercard American Express Maestro Discover JCB PayPal Google Pay
Visa Secure Mastercard Identity Check American Express SafeKey

Gilead Sciences Inc., consolidated balance sheet: liabilities and stockholders’ equity (quarterly data)

US$ in millions

Microsoft Excel
Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Accounts payable
Accrued rebates
Current portion of long-term debt, net
Other current liabilities
Current liabilities
Long-term debt, net, excluding current portion
Long-term income taxes payable
Deferred tax liability
Other long-term obligations
Long-term liabilities
Total liabilities
Preferred stock, par value $0.001 per share; none outstanding
Common stock, par value $0.001 per share
Additional paid-in capital
Accumulated other comprehensive income (loss)
Retained earnings
Total Gilead stockholders’ equity
Noncontrolling interest
Total stockholders’ equity
Total liabilities and stockholders’ equity

Based on: 10-Q (reporting date: 2025-03-31), 10-K (reporting date: 2024-12-31), 10-Q (reporting date: 2024-09-30), 10-Q (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-K (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31).

Accounts Payable
The accounts payable values show fluctuations without a clear consistent trend, with initial values around 590 million USD in early 2020, peaking at 905 million USD in December 2022, followed by a decline to 550 million USD in December 2023, and rising again to 833 million USD by March 2025.
Accrued Rebates
Accrued rebates demonstrate a generally increasing trajectory from 3,457 million USD in March 2020 to peaks above 4,000 million USD in late 2024 and early 2025, indicating growing obligations in rebate accruals with some variability quarter-to-quarter.
Current Portion of Long-Term Debt, Net
This liability shows marked volatility, with values ranging from around 1,021 million USD in mid-2022 to spikes over 4,000 million USD in mid-2023, suggesting significant refinancing activity or shifting debt maturities within the company's current liabilities.
Other Current Liabilities
These liabilities generally increased during 2021 and 2022, hitting highs over 5,800 million USD at multiple points late 2022 to early 2023, but subsequently fluctuated and slightly declined toward early 2025, suggesting variable short-term obligations or accrued expenses.
Current Liabilities
Overall, current liabilities exhibit a cyclical pattern with peaks around late 2021 and mid-2023, reaching nearly 14,000 million USD, followed by moderate decreases, indicating fluctuating short-term financial responsibilities likely linked to working capital dynamics.
Long-Term Debt, Net, Excluding Current Portion
Long-term debt displayed significant changes, with notable increases in late 2020 reaching above 28,000 million USD, stability through 2022 at approximately 22,000 to 25,000 million USD, slight decreases through 2023, but a renewed increase up to 24,896 million USD in late 2024, reflecting active debt management and issuance.
Long-Term Income Taxes Payable
This liability steadily decreased from about 5,595 million USD in early 2020 to under 1,000 million USD by late 2024, signaling a sustained reduction in deferred tax liabilities or settlements of income tax obligations over time.
Deferred Tax Liability
Data on deferred tax liability begins only in late 2020, showing a clear declining trend from nearly 4,000 million USD to around 700 million USD by early 2025, suggesting decreasing deferred tax exposures possibly linked to tax planning or asset amortizations.
Other Long-Term Obligations
Values for other long-term obligations remained relatively stable, fluctuating modestly between 900 and 1,400 million USD, with no significant upward or downward trend, indicating consistent long-term commitments.
Long-Term Liabilities
Long-term liabilities peaked at nearly 39,000 million USD in late 2020, followed by a steady decline to around 25,000 million USD by early 2025, reflecting overall debt reduction or liability restructuring over the period.
Total Liabilities
Total liabilities reached a historic high above 50,000 million USD at the end of 2020, then progressively declined to between 35,000 and 39,000 million USD through 2024, before slightly increasing again in early 2025, illustrating cautious balance sheet management and liability optimization.
Common Stock and Capital Structure
Common stock par value remained constant at 1 million USD throughout the period, while additional paid-in capital increased steadily from 3,311 million USD to over 8,100 million USD by early 2025, indicating consistent capital infusions or equity issuances over time.
Accumulated Other Comprehensive Income (Loss)
This equity component exhibited fluctuations around modest positive values, ranging from negative 60 million USD to positive 132 million USD, reflecting variable unrealized gains or losses affecting comprehensive income.
Retained Earnings
Retained earnings fluctuated notably, peaking near 16,900 million USD in late 2021, then declining sharply to near 10,600 million USD by early 2024, followed by minor recoveries, indicating periods of accumulated profits offset by distributions or losses.
Total Stockholders’ Equity
Stockholders' equity varied substantially, rising from about 22,000 million USD early 2020 to a peak above 22,800 million USD in late 2023, then falling to approximately 17,400 million USD in mid-2024 before modestly recovering, reflecting underlying fluctuating earnings, capital transactions, and comprehensive income impacts.
Noncontrolling Interest
The noncontrolling interest declined steadily from positive values to negative 84 million USD by early 2024, persisting at this level thereafter, indicating diminishing outside ownership interests or reclassifications within subsidiaries.
Total Liabilities and Stockholders' Equity
The combined total exhibited a peak near 68,400 million USD at the end of 2020, followed by a gradual overall decrease to mid-50,000 million USD by early 2025, consistent with the patterns of declining liabilities and equity fluctuations, reflecting net asset adjustments and business scale changes over the period.